Vanguard Group’s ReShape Lifesciences Inc. Common Stock RSLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-196
Closed -$1K 4171
2018
Q3
$1K Sell
196
-98
-33% -$8.43K ﹤0.01% 4168
2018
Q2
$95K Buy
294
+37
+14% +$31.6K ﹤0.01% 4055
2018
Q1
$781K Buy
257
+125
+95% +$398K ﹤0.01% 3707
2017
Q4
$410K Buy
+132
New +$437K ﹤0.01% 3792

Other funds holding RSLS